PTIX Protagenic Therapeutics Soliqdan keyingi foyda

Protagenic Therapeutics (PTIX) korporativ emblemasi va logotipi

Neyronlarni tartibga solishga bo'lgan innovatsion yondashuv Protagenic Therapeutics (PTIX) kompaniyasiga ruhiy buzilishlarni davolashda raqobatbardosh ustunlikni taqdim etadi, bu esa kompaniyaning yillik sof foyda dinamikasini qo'llab-quvvatlaydi. Hozirgi vaqtda -0.01 eng so'nggi metrika ko'rsatkichini ifodalaydi. Biznes asosi PT00114 sintetik peptidlarining kengayishiga tayanadi; biroq, daromadning yo'qligi va investitsiyalarga bog'liqlik loyiha uchun jiddiy ekzistensial xavflarni yuzaga keltirmoqda.

PTIX (protagenic.com) Kompaniyaning sof foydasi tarixi 04.07.2022dan 10.01.2026gacha

protagenic.com (PTIX) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Protagenic Therapeutics, Inc.|PTIX - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi Protagenic Therapeutics, Inc.|PTIX - Kompaniyaning to‘liq qiymati
- emitentning balans qiymati statistikasi:
Aksiyaning buxgalteriya qiymati Protagenic Therapeutics|PTIX - Kompaniyaning balans qiymati|Bozor qiymatining balans qiymatiga koeffitsiyenti protagenic.com|PTIX - Kompaniyaning yakuniy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Jamlagan qarzning kapitalga nisbati Protagenic Therapeutics|PTIX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Protagenic Therapeutics, Inc.|PTIX - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Protagenic Therapeutics, Inc.|PTIX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Protagenic Therapeutics|Shoshilinch likvidlik koeffitsiyenti protagenic.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PTIX - Sof foyda
Fundamental baholash:PTIX (Protagenic)
protagenic.com yetakchi tovari

Yuqori sifatli aktivlarni tanlash uchun investor sof foydaning kunlik ulushini ob'ektiv baholash orqali kapital barqarorligini tasdiqlashi kerak. Ushbu ko'rsatkich kunlik biznes samaradorligini o'lchaydi, bu esa gormonal terapiya uchun neyrobiologik tadqiqotlarga investitsiya kiritayotgan sog'liqni saqlash giganti Protagenic Therapeutics (PTIX) uchun kompaniyaning sof foyda dinamikasini tahlil qilish orqali sheriklik monetizatsiyasini kuzatish va debitorlik qarzdorliklari risklarini yumshatish imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|regencellbioscience.com - Soliqdan keyingi foyda|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|ACAD (ACADIA Pharma) - Yakuniy foyda|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Viking Therapeutics Corp (VKTX) - Kompaniyaning sof daromadi|SUPN: Sof daromad|catalystpharma.com - Soliqlar to‘langandan keyingi foyda|DNLI: Sof foyda|Harmony Biosciences Inc (HRMY) - Sof foyda|BHVN (Biohaven Pharmaceutical) - Sof foyda|AMLX - Yillik sof foyda|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CBLL: Kompaniya foydasi|Prothena Biosciences - Sof foyda|Sof moliyaviy natija Alector, Inc. ALEC|ANNX: Sof foyda|Sof daromad Omeros|Sof daromad NGNE|ACIU: Yakuniy foyda|Sof daromad VYGR (Voyager Pharma)|Soliqlar to‘langandan keyingi foyda NMRA|Sof foyda SCLX (Scilex Holding Company)|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|Kompaniyaning sof daromadi cogrx.com|Inhibikase (IKT) - Kompaniyaning sof foydasi|Cassava Pharma - Yakuniy foyda|ASRT (Assertio Holdings) - Sof foyda|Sof foyda Coya|Kompaniyaning sof foydasi Vistagen Therapeutics (VTGN)|OVID: Soliqdan keyingi foyda|Sof foyda ABOS (Acumen Pharma)|CervoMed Corporation (CRVO) - Kompaniyaning sof daromadi|ATHE: Sof daromad|CLNN - Sof foyda|PEPG (pepgen.com) - Sof daromad|JUNS: Soliqlar to‘langandan keyingi foyda|RLMD (Relmada) - Sof foyda|Annovis Bio Corporation (ANVS) - Sof moliyaviy natija|Sof foyda GRCE|Sof daromad fireflyneuro.com AIFF|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Sof moliyaviy natija NeuroSense Therapeutics Ltd (NRSN)|RVPH - Kompaniyaning sof foydasi|Soliqdan keyingi foyda MTVA|NRXS (NeurAxis, Inc.) - Sof daromad|HSDT: Soliqlar to‘langandan keyingi foyda|PASG (Passage Bio Inc.) - Sof foyda|Neuphoria (NEUP) - Sof moliyaviy natija|Sof daromad NERV (Minerva Neurosciences Corp)|Athira Pharma Corp - Kompaniya foydasi|Kompaniyaning sof foydasi Addex Therapeutics ADXN|ALZN: Kompaniya foydasi|Cyclerion - Sof foyda|Kompaniyaning sof daromadi Pasithea Therapeutics|CRGT (cortigent.com) - Sof daromad|Avenue Therapeutics Inc (ATXI) - Sof foyda|Kompaniyaning sof foydasi Brainstorm Cell|CARA: Yakuniy foyda|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|ELYM - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH (Longboard) - Soliqdan keyingi foyda|MRNS - Kompaniyaning sof foydasi|Yakuniy foyda NKGN (nkgenbiotech.com)|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Sage Therapeutics Inc. (SAGE)|Sof daromad SNPX|TRVN (Trevena Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda VIGL|Sof foyda Anew Medical Inc. (WENA)|Sof foyda CERE (Cerevel Therapeutics, Inc.)